FHIR Implementation Guide for NJSAMS
1.0.0 - release
1.0.0 - release
NJSAMS - Local Development build (v1.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: https://fhir.njsams.rutgers.edu/NJSAMS-fhir/Questionnaire/StimulantUseDisordersQuestionnaire | Version: 1.0.0 | |||
| Draft as of 2022-08-31 | Computable Name: | |||
Criteria for Stimulant Use Disorder
Generated Narrative: Questionnaire StimulantUseDisordersQuestionnaire
| LinkID | Text | Cardinality | Type | Description & Constraints |
|---|---|---|---|---|
  | Criteria for Stimulant Use Disorder | Questionnaire | https://fhir.njsams.rutgers.edu/NJSAMS-fhir/Questionnaire/StimulantUseDisordersQuestionnaire#1.0.0 | |
  StimulantUseDisorder | A. A pattern of amphetamine-type substance, cocaine, or other stimulant use leading to clinically significant impairment or distress, as manifested by at least two of the following, occurring within a 12-month period: | 0..1 | group | |
  StimulantUseDisorder.602 | 602. The stimulant is often taken in larger amounts or over a longer period than was intended. | 0..1 | boolean | |
| StimulantUseDisorder.603 | 603. There is a persistent desire or unsuccessful efforts to cut down or control stimulant use. | 0..1 | boolean | |
| StimulantUseDisorder.604 | 604. A great deal of time is spent in activities necessary to obtain the stimulant, use the stimulant, or recover from its effects. | 0..1 | boolean | |
| StimulantUseDisorder.605 | 605. Craving, or a strong desire or urge to use the stimulant. | 0..1 | boolean | |
| StimulantUseDisorder.606 | 606. Recurrent stimulant use resulting in a failure to fulfill major role obligations at work, school, or home. | 0..1 | boolean | |
| StimulantUseDisorder.607 | 607. Continued stimulant use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the stimulant. | 0..1 | boolean | |
| StimulantUseDisorder.608 | 608. Important social, occupational, or recreational activities are given up or reduced because of stimulant use. | 0..1 | boolean | |
| StimulantUseDisorder.609 | 609. Recurrent stimulant use in situations in which it is physically hazardous. | 0..1 | boolean | |
| StimulantUseDisorder.610 | 610. Stimulant use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the stimulant. | 0..1 | boolean | |
| StimulantUseDisorder.611 | 611. Tolerance, as defined by either of the following: a. A need for markedly increased amounts of the stimulant to achieve intoxication or desired effect. b. A markedly diminished effect with continued use of the same amount of the stimulant. Note:This criterion is not considered to be met for those taking stimulant medications solely under appropriate medical supervision, such as medications for attention-deficit/hyperactivity disorder or narcolepsy. | 0..1 | boolean | |
| StimulantUseDisorder.614 | 614. Withdrawal, as manifested by either of the following: a. The characteristic withdrawal syndrome for the stimulant [refer to Criteria A and B of the criteria set for stimulant withdrawal, p.272]. b. The stimulant[or a closely related substance] is taken to relieve or avoid withdrawal symptoms. | 0..1 | boolean | |
 StimulantUseDisorder.1 | selectedStimulant | 0..1 | choice | Value Set: NJSAMS Stimulant |
  StimulantUseDisorder.2 | stimulantName | 0..1 | text | |
| StimulantIntoxication | null | 0..1 | group | |
| StimulantIntoxication.625 | 625.A. Recent use of amphetamine-type substance, cocaine or other stimulant | 0..1 | boolean | |
| StimulantIntoxication.626 | 626.B. Clinically significant problematic behavioral or psychological changes [e.g.,euphoria or affective blunting; changes in sociability; hypervigilance; interpersonal sensitivity; anxiety, tension, or anger; stereotyped behaviors; impaired judgment] that developed during, or shortly after, use of a stimulant., or home. | 0..1 | boolean | |
| SideEffects | C. Two (or more) of the following, developing during, or shortly after stimulant use | 0..1 | group | |
| StimulantIntoxication.SideEffects.628 | 628. Tachycardia or bradycardia | 0..1 | boolean | |
| StimulantIntoxication.SideEffects.629 | 629. Pupillary dilation | 0..1 | boolean | |
| StimulantIntoxication.SideEffects.630 | 630. Elevated or lowered blood pressure | 0..1 | boolean | |
| StimulantIntoxication.SideEffects.631 | 631. Perspiration or chills | 0..1 | boolean | |
| StimulantIntoxication.SideEffects.632 | 632. Nausea or vomiting | 0..1 | boolean | |
| StimulantIntoxication.SideEffects.633 | 633. Evidence of weight loss | 0..1 | boolean | |
| StimulantIntoxication.SideEffects.634 | 634. Psychomotor agitation or retardation | 0..1 | boolean | |
| StimulantIntoxication.SideEffects.635 | 635. Muscular weakness, respiratory depression, chest pain, or cardiac arrhythmias | 0..1 | boolean | |
| StimulantIntoxication.SideEffects.636 | 636. Confusion, seizures, dyskinesias, dystonias, or coma | 0..1 | boolean | |
| StimulantIntoxication.637 | 637.D. The symptoms are not due to a general medical condition and are not better accounted for by another mental disorder, dystonias, or coma | 0..1 | boolean | |
| StimulWithdrawSymptoms | null | 0..1 | group | |
| StimulWithdrawSymptoms.650 | 650.A. Cessation of [or reduction in] prolonged amphetamine-type substance, cocaine, or other stimulant use. | 0..1 | boolean | |
| SideEffects | B. Dysphoric mood and two (or more) of the following physiological changes, developing within a few hours to several days after Criterion A: | 0..1 | group | |
| StimulWithdrawSymptoms.SideEffects.652 | 652. Fatigue | 0..1 | boolean | |
| StimulWithdrawSymptoms.SideEffects.653 | 653. Vivid, unpleasant dreams | 0..1 | boolean | |
| StimulWithdrawSymptoms.SideEffects.654 | 654. Insomnia or hypersomnia | 0..1 | boolean | |
| StimulWithdrawSymptoms.SideEffects.655 | 655. Increased appetite | 0..1 | boolean | |
| StimulWithdrawSymptoms.SideEffects.656 | 656. Psychomotor retardation or agitation | 0..1 | boolean | |
| StimulWithdrawSymptoms.657 | 657.C. The signs or symptoms in Criterion B cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. | 0..1 | boolean | |
| StimulWithdrawSymptoms.658 | 658.D. The signs or symptoms are not attributable to another medical condition and are not better explained by another mental disorder, including intoxication or withdrawal from another substance. | 0..1 | boolean | |
| StimulUnspecifiedSymptoms | null | 0..1 | group | |
| StimulUnspecifiedSymptoms.665 | 665. This category applies to presentations in which symptoms characteristic of an stimulant-related disorder that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning predominate but do not meet the full criteria for any specific stimulant-related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class. | 0..1 | boolean | |
| meetsStimulIntoxCriteria | null | 0..1 | group | |
 meetsStimulIntoxCriteria.1 | Specify Withdrawal Substance Name: | 0..1 | text | |
| Documentation for this format | ||||